Barbara Dewaele News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SAN DIEGO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and...

SAN DIEGO, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and...

Caleb Clifford May 21, 2021 Bionano Genomics Inc. [NASDAQ: BNGO] traded at a low on 07/23/21, posting a -3.08 loss after which it closed the day’ session at $5.97. The company report on July 19, 2021 that Bionano’s Optical Genome Mapping for Acute Lymphoblastic Leukemia Subjects at the University Hospitals Leuven, Belgium, Has Faster Turnaround Time, Higher Success Rates and Lower Cost per Sample Compared to Traditional Methods. Bionano Genomics, Inc. (Nasdaq: BNGO) announces a summary of the results obtained by the University Hospitals Leuven, Belgium with optical genome mappi...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Day Two of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Outperforms Standard ... Bionano GenomicsJanuary 13, 2021 GMT ADVERTISEMENT SAN DIEGO, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that day two of its five-day Next-Generation Cytogenomics Symposium featured eight Saphyr users presenting their results and experiences using the Saphyr® system for optical genome mapping (OGM) to analyze the genomes of patients with heme malignancies. The presen...